PharmaCyte Biotech Makes $7 Million Strategic Investment in MyMD, A Biopharmaceutical Company Focused on Inflammatory Disease
Second external investment in life sciences solidifies previously announced strategy to utilize significant cash position to create additional stockholder value ...
Chris Chapman Michael Abecassis Company Board Of Directors Business Review Committee Mymd Pharmaceuticals Inc Drug Administration
Source: marketscreener.com